Deficient activation and different expression of transforming growth factor-β isoforms in active proliferative diabetic retinopathy and neovascular eye disease

Abstract
An increased expression and secretion of angiogenic growth factors was proposed to occur in proliferative diabetic retinopathy and other neovascularizing retinal diseases. However, a loss of anti-angiogenic factors also might promote retinal neovascularization. Therefore we investigated the active and latent vitreous levels of the subtypes of the endothelial anti-mitogen transforming growth factor-beta in vitreous of 58 patients. Four groups of patients were compared: Controls without retinal hypoxia, patients with quiescent and active proliferative diabetic retinopathy (PDR), and patients with severe retinal hypoxia resulting in rubeosis iridis. Whereas the amount of total TGF-β in the four groups did not differ significantly, latent TGF-β isoform expression showed complex alterations in ocular vitreous. Levels of active TGF-β of patients with active PDR (79.5 ± 28 pg/ml; n = 8) were decreased to 20% of the control levels (378 ± 55 pg/ml; n = 12; p = 0.0005) and 25 % of the mean concentration in quiescent PDR (346 ± 64 pg/ml; n = 9; p = 0.0021). Levels in rubeosis (52 ± 10 pg/ml; n = 10) did not differ significantly from those found in active PDR but were decreased to 15% of those in patients with quiescent PDR (p = 0.0004). Furthermore a highly significant inverse correlation between active TGF-β and alpha2-antiplasmin, a liver produced inhibitor of the activation of TGF-β by plasmin was noted (r = -0.59; n = 28; p = 0.001). We conclude that deficient activation of TGF-β occurs in active proliferative diabetic retinopathy and in hypoxic angiogenesis most likely as a consequence of a blood retina barrier breakdown and influx of alpha2-antiplasmin from serum. The disinhibition of endothelial cell proliferation may be a central component in the process of neovascularization.

This publication has 0 references indexed in Scilit: